Current knowledge of Ipilimumab and its use in treating non-small cell lung cancer Article

Pinto, Joseph A, Raez, Luis E, Oliveres, Helena et al. (2019). Current knowledge of Ipilimumab and its use in treating non-small cell lung cancer . EXPERT OPINION ON BIOLOGICAL THERAPY, 19(6), 509-515. 10.1080/14712598.2019.1610380

Open Access International Collaboration

cited authors

  • Pinto, Joseph A; Raez, Luis E; Oliveres, Helena; Rolfo, Christian C

sustainable development goals

authors

publication date

  • June 3, 2019

webpage

published in

keywords

  • 1ST-LINE TREATMENT
  • ADVERSE EVENTS
  • Biotechnology & Applied Microbiology
  • CLINICAL-RESPONSE
  • CTLA-4
  • CTLA-4 BLOCKADE
  • EXPANDED ACCESS PROGRAM
  • IMMUNE CHECKPOINT INHIBITORS
  • Life Sciences & Biomedicine
  • METASTATIC MELANOMA
  • Medicine, Research & Experimental
  • Non-small cell lung cancer
  • PHASE-I
  • PLUS IPILIMUMAB
  • Research & Experimental Medicine
  • Science & Technology
  • T-CELLS
  • biomarkers
  • immunotherapy

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 509

end page

  • 515

volume

  • 19

issue

  • 6